125 related articles for article (PubMed ID: 37723066)
21. Transjugular Intrahepatic Portosystemic Shunt for Very Severe Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) after Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation with Post-transplantation Cyclophosphamide.
Gómez-Centurión I; Bailén R; Oarbeascoa G; Muñoz C; Luque AÁ; Boyra ME; Calleja E; Rincón D; Dorado N; Barzallo P; Anguita J; Díez-Martín JL; Kwon M
Biol Blood Marrow Transplant; 2020 Nov; 26(11):2089-2097. PubMed ID: 32791193
[TBL] [Abstract][Full Text] [Related]
22. Percutaneous transhepatic intrahepatic portosystemic shunt for variceal bleeding with chronic portal vein occlusion after splenectomy.
Luo J; Li M; Zhang Y; Wang H; Huang M; Li Z; Chen J; Wu C; Qian J; Guan S; Jiang Z
Eur Radiol; 2018 Sep; 28(9):3661-3668. PubMed ID: 29600476
[TBL] [Abstract][Full Text] [Related]
23. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
[TBL] [Abstract][Full Text] [Related]
24. [Study on the comparative analysis of the efficacy of transmesenteric vein extrahepatic portosystemic shunt and transjugular intrahepatic portosystemic shunt in the treatment of cavernous transformation of portal vein].
Zhu YD; Li WX; Cui MZ; Wang H; Yang HP; Zhai ST
Zhonghua Gan Zang Bing Za Zhi; 2023 Jan; 31(1):90-95. PubMed ID: 36948855
[No Abstract] [Full Text] [Related]
25. Short- and long-term hemodynamic effects of transjugular intrahepatic portosystemic shunts: a Doppler/manometric correlative study.
Lafortune M; Martinet JP; Denys A; Patriquin H; Dauzat M; Dufresne MP; Colombato L; Pomier-Layrargues G
AJR Am J Roentgenol; 1995 Apr; 164(4):997-1002. PubMed ID: 7726065
[TBL] [Abstract][Full Text] [Related]
26. Percutaneous transhepatic balloon-assisted transjugular intrahepatic portosystemic shunt for chronic, totally occluded, portal vein thrombosis with symptomatic portal hypertension: procedure technique, safety, and clinical applications.
Chen Y; Ye P; Li Y; Ma S; Zhao J; Zeng Q
Eur Radiol; 2015 Dec; 25(12):3431-7. PubMed ID: 25903717
[TBL] [Abstract][Full Text] [Related]
27. Transjugular intrahepatic portosystemic shunt creation with the Viatorr expanded polytetrafluoroethylene-covered stent-graft.
Hausegger KA; Karnel F; Georgieva B; Tauss J; Portugaller H; Deutschmann H; Berghold A
J Vasc Interv Radiol; 2004 Mar; 15(3):239-48. PubMed ID: 15028808
[TBL] [Abstract][Full Text] [Related]
28. [Transjugular intrahepatic portosystemic shunt for the treatment cavernous transformation of the portal vein with vareceal bleeding].
Guo FF; Wu ZY; Zhou PL; Han XW
Zhonghua Yi Xue Za Zhi; 2020 Feb; 100(5):387-390. PubMed ID: 32074785
[No Abstract] [Full Text] [Related]
29. Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage.
Jalan R; Elton RA; Redhead DN; Finlayson ND; Hayes PC
J Hepatol; 1995 Aug; 23(2):123-8. PubMed ID: 7499782
[TBL] [Abstract][Full Text] [Related]
30. Outcomes of combination treatment with MARS and TIPS for hepatic veno-occlusive disease: a report of 12 cases.
Deng L; Yin X; Zhao Y; Yang J; Yang H; Xu C; Li K
J Int Med Res; 2020 Dec; 48(12):300060520980877. PubMed ID: 33372815
[TBL] [Abstract][Full Text] [Related]
31. [Hepatic venousaplasty and transjugular intrahepatic portosystemic shunt in the treatment of Budd-Chiari syndrome with occlusion of the hepatic veins].
Wu XJ; Cao JM; Han JM; Li JS
Zhonghua Wai Ke Za Zhi; 2013 Feb; 51(2):131-4. PubMed ID: 23711005
[TBL] [Abstract][Full Text] [Related]
32. Successful treatment of severe azathioprine-induced hepatic veno-occlusive disease in a kidney-transplanted patient with transjugular intrahepatic portosystemic shunt.
Azoulay D; Castaing D; Lemoine A; Samuel D; Majno P; Reynes M; Charpentier B; Bismuth H
Clin Nephrol; 1998 Aug; 50(2):118-22. PubMed ID: 9725784
[TBL] [Abstract][Full Text] [Related]
33. [Effect of covered stent length in portal and hepatic veins on long-term clinical efficacy of transjugular intrahepatic portosystemic shunt].
Hu P; Chen SL; Lin ZP; Zhao JB; Chen Y; He XF; Zeng QL; Li YH
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Oct; 36(10):1444-1448. PubMed ID: 27777214
[TBL] [Abstract][Full Text] [Related]
34. Transjugular liver biopsy after transjugular intrahepatic portosystemic shunt (TIPS) or direct intrahepatic portocaval shunt (DIPS): Is it feasible, effective, and safe?
Kaufman C; Aryafar H; Minocha J; Kinney T
Diagn Interv Imaging; 2018 May; 99(5):331-335. PubMed ID: 29366793
[TBL] [Abstract][Full Text] [Related]
35. Successful treatment of hepatic veno-occlusive disease in a peripheral blood progenitor cell transplant patient with a transjugular intrahepatic portosystemic stent-shunt (TIPS).
de la Rubia J; Carral A; Montes H; Urquijo JJ; Sanz GF; Sanz MA
Haematologica; 1996; 81(6):536-9. PubMed ID: 9009442
[TBL] [Abstract][Full Text] [Related]
36. Management of refractory hepatic encephalopathy after insertion of TIPS: long-term results of shunt reduction with hourglass-shaped balloon-expandable stent-graft.
Fanelli F; Salvatori FM; Rabuffi P; Boatta E; Riggio O; Lucatelli P; Passariello R
AJR Am J Roentgenol; 2009 Dec; 193(6):1696-702. PubMed ID: 19933667
[TBL] [Abstract][Full Text] [Related]
37. Controlled underdilation using novel VIATORR® controlled expansion stents improves survival after transjugular intrahepatic portosystemic shunt implantation.
Praktiknjo M; Abu-Omar J; Chang J; Thomas D; Jansen C; Kupczyk P; Schepis F; Garcia-Pagan JC; Merli M; Meyer C; Strassburg CP; Pieper CC; Trebicka J
JHEP Rep; 2021 Jun; 3(3):100264. PubMed ID: 34013182
[TBL] [Abstract][Full Text] [Related]
38. Detection of transjugular intrahepatic portosystemic shunt dysfunction: value of duplex Doppler sonography.
Dodd GD; Zajko AB; Orons PD; Martin MS; Eichner LS; Santaguida LA
AJR Am J Roentgenol; 1995 May; 164(5):1119-24. PubMed ID: 7717217
[TBL] [Abstract][Full Text] [Related]
39. Current role of portosystemic shunt surgery in the management of hepatic venous outflow obstruction.
Singhal D; de Castro S; Goyal N; Gouma DJ; Chaudhary A; van Gulik TM
Dig Surg; 2006; 23(5-6):358-69. PubMed ID: 17164547
[TBL] [Abstract][Full Text] [Related]
40. Risk factors for overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt creation in patients with liver cirrhosis.
Tong H; Gan C; Wei B; Wang ZD; Li XD; Qian SJ; Huan H; Zhang LH; Yang Z; Chen YL; Gu YH; Chen LX; Yang YH; Wu H; Tang CW
J Dig Dis; 2021 Jan; 22(1):31-40. PubMed ID: 33128287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
